Michael Wyzga
Nessuna posizione attualmente
Profilo
Michael D.
Wyzga served as Vice President-Healthcare Investment at Needham & Co. LLC from 2018 to 2021.
Prior to that, he was the Chief Financial Officer and Senior VP at Yumanity Therapeutics, Inc. and Kineta, Inc. respectively.
He completed his undergraduate degree at Lehigh University and earned an MBA from SC Johnson College of Business.
Precedenti posizioni note di Michael Wyzga
| Società | Posizione | Fine |
|---|---|---|
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Corporate Officer/Principal | 01/08/2021 |
| KINETA, INC. | Director of Finance/CFO | - |
| YUMANITY THERAPEUTICS | Director of Finance/CFO | - |
Formazione di Michael Wyzga
| Lehigh University | Undergraduate Degree |
| SC Johnson College of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KINETA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Finance |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Wyzga
